NCT03431181View on ClinicalTrials.gov

Optimal VAsopressor TitraTION in Patients 65 Years and Older

NAActive, not recruitingINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

February 16, 2018

Primary Completion Date

February 21, 2020

Study Completion Date

December 31, 2024

Conditions
VasopressorsHypotensionMean Arterial Pressure TargetsUsual Care
Interventions
BEHAVIORAL

MAP target 60-65 mmHg

Treating teams will adjust vasopressors to a target MAP range of 60 to 65 mmHg, avoiding vasopressor-induced MAP above this range.

BEHAVIORAL

Usual care

Patients in the control arm will receive usual care (as per local practices).

Trial Locations (1)

J1H5N4

CIUSSS de l'Estrie-CHUS, Sherbrooke

All Listed Sponsors
lead

Université de Sherbrooke

OTHER

NCT03431181 - Optimal VAsopressor TitraTION in Patients 65 Years and Older | Biotech Hunter | Biotech Hunter